» Articles » PMID: 17977970

Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them Between Cytoplasmic Sites of MRNA Metabolism

Overview
Journal J Virol
Date 2007 Nov 6
PMID 17977970
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Vif(IIIB), which has been a standard model for the viral infectivity factor of human immunodeficiency virus type 1 (HIV-1), binds the cytidine deaminase APOBEC3G (A3G) and induces its degradation, thereby precluding its lethal incorporation into assembling virions. Additionally, Vif(IIIB) less efficiently degrades A3F, another potent anti-HIV-1 cytidine deaminase. Although the APOBEC3 paralogs A3A, A3B, and A3C have weaker anti-HIV-1 activities and are only partially degraded by Vif(IIIB), we found that Vif(IIIB) induces their emigration from the nucleus to the cytosol and thereby causes net increases in the cytosolic concentrations and anti-HIV-1 activities of A3A and A3B. In contrast, some other Vifs, exemplified by Vif(HXB2) and Vif(ELI-1), much more efficiently degrade and thereby neutralize all APOBEC3s. Studies focused mainly on A3F imply that it occurs associated with mRNA-PABP1 in translationally active polysomes and to a lesser extent in mRNA processing bodies (P-bodies). A3F appears to stabilize the P-bodies with which it is associated. A correspondingly small proportion of Vif(IIIB) also localizes in P-bodies in an A3F-dependent manner. Stress causes A3A, A3B, A3C, and A3F to colocalize efficiently with Vif(IIIB) and mRNA-PABP1 complexes in stress granules in a manner that is prevented by cycloheximide, an inhibitor of translational elongation. Coimmunoprecipitation studies suggest that Vifs from different HIV-1 isolates associate with all tested APOBEC3s. Thus, Vifs interact closely with structurally diverse APOBEC3s, with effects on their subcellular localization, degradation rates, and antiviral activities. Cytosolic APOBEC3-Vif complexes are predominantly bound to mRNAs that dynamically move between translationally active and storage or processing pools.

Citing Articles

APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution.

Shen J, Xu X, Fan J, Chen H, Zhao Y, Huang W Heliyon. 2024; 10(11):e32139.

PMID: 38868014 PMC: 11168432. DOI: 10.1016/j.heliyon.2024.e32139.


A Conserved uORF Regulates APOBEC3G Translation and Is Targeted by HIV-1 Vif Protein to Repress the Antiviral Factor.

Libre C, Seissler T, Guerrero S, Batisse J, Verriez C, Stupfler B Biomedicines. 2022; 10(1).

PMID: 35052693 PMC: 8773096. DOI: 10.3390/biomedicines10010013.


APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.

Bandarra S, Miyagi E, Ribeiro A, Goncalves J, Strebel K, Barahona I J Virol. 2021; 95(23):e0117021.

PMID: 34523960 PMC: 8577350. DOI: 10.1128/JVI.01170-21.


Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein.

Stupfler B, Verriez C, Gallois-Montbrun S, Marquet R, Paillart J Viruses. 2021; 13(4).

PMID: 33916704 PMC: 8066197. DOI: 10.3390/v13040617.


The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.

Granadillo Rodriguez M, Flath B, Chelico L Open Biol. 2020; 10(12):200188.

PMID: 33292100 PMC: 7776566. DOI: 10.1098/rsob.200188.


References
1.
Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D . Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem. 2003; 279(9):7792-8. DOI: 10.1074/jbc.M313093200. View

2.
Sheehy A, Gaddis N, Malim M . The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med. 2003; 9(11):1404-7. DOI: 10.1038/nm945. View

3.
Wiegand H, Doehle B, Bogerd H, Cullen B . A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 2004; 23(12):2451-8. PMC: 423288. DOI: 10.1038/sj.emboj.7600246. View

4.
Kshirsagar M, Parker R . Identification of Edc3p as an enhancer of mRNA decapping in Saccharomyces cerevisiae. Genetics. 2004; 166(2):729-39. PMC: 1470743. DOI: 10.1534/genetics.166.2.729. View

5.
Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P . Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 2003; 302(5647):1056-60. DOI: 10.1126/science.1089591. View